Table 2.
Cathepsin B inhibitors and their appropriate mechanism of action available to inhibit cathepsin B
Inhibitor | Chemistry | Mechanism | Source | Reference |
---|---|---|---|---|
Z-Phe-AlaCH2F | fluoromethyl ketone 3-(N-benzyloxycarbonylphenylalanylamido)-DL-1-fluoro-2-butanone | Irreversible covalent inhibitor | synthesized | Rasnick D. Synthesis of peptide fluoromethyl ketones and the inhibition of human Cathepsin B. Anal Biochem. 1985 Sep;149(2):461–5. |
E-64 | C15N5H2705 | Irreversible covalent inhibitor | Aspergillus japonicus TPR-64 | Hanada K, Tamai M, Yamagishi M, Ohmura S, Sawada J, Tanaka I. Isolation and characterization of E-64, a new thiol protease inhibitor. Agric Biol Chem. 1978;42:523–528. |
E64d | EST, Loxistatin, ethyl (2S,3S)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate | Irreversible covalent inhibitor | synthesized | Hashida S, Towatari T, Kominami E, Katunuma N. Inhibitions by E-64 derivatives of rat liver Cathepsin B and Cathepsin L in vitro and in vivo. J Biochem. 1980 Dec;88(6):1805–11. |
iodo and diiodotyrosine E-64-c analogs | Iodo and diiodotyrosine epoxysuccinyl derivatives | Irreversible covalent inhibitor | synthesized | Giordano C, Calabretta R, Gallina C, Consalvi V, Scandurra R, Noya FC. Iodo and diiodotyrosine epoxysuccinyl derivatives as selective inhibitors of Cathepsin B. Eur J Med Chem. 1993;28:917–926. |
CA-074 and its derivates ( CA-074 Me) | [L-3-trans-(propylcarbamoyl)oxirane-2- carbonyl]-L-isoleucyl-L-proline | Irreversible covalent inhibitor | synthesized | Montaser M, Lalmanach G, Mach L. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of Cathepsin B within living cells. Biol Chem. 2002 Jul-Aug;383(7–8):1305–8. |
Miraziridine A | aziridinylpeptide | Irreversible covalent inhibitor | Theonella mirabilis Theonella swinhoei | Nakao Y, Fujita M, Warabi K, Matsunaga S, Fusetani N. Miraziridine A a novel cysteine protease inhibitor from the marine sponge theonella aff. mirabilis. J Am Chem Soc. 2000;122:10462– 10463. |
Bz-Phe-Arg-CH2F | peptide derivative of arginylfluoromethane | Irreversible covalent inhibitor | synthesized | Angliker H, Wikström P, Rauber P, Stone S, Shaw E. Synthesis and properties of peptidyl derivatives of arginylfluoromethanes. Biochem J. 1988 Dec 1;256(2):481–6. |
diazomethyl ketones | Benzyloxycarbonyl-phenylalanyl diazomethyl ketone and benzyloxy-carbonyl-phenylalanyl-phenylalanyl diazomethyl ketone | Irreversible covalent inhibitor | synthesized | Leary R, Shaw E. Inactivation of Cathepsin B1 by diazomethyl ketones. Biochem Biophys Res Commun. 1977 Dec 7;79(3):926–31. |
peptidyl (acyloxy)methanes | peptidyl (acyloxy)methanes | Irreversible covalent inhibitor | synthesized | Krantz A. Peptidyl (acyloxy)methanes as quiescent affinity labels for cysteine proteinases. Methods Enzymol. 1994;244:656–71. |
1,2,4-thiadiazole derivate | thiadiazoles 3a–h | Irreversible covalent inhibitor | synthesized | Leung-Toung R, Wodzinska J, Li W, Lowrie J, Kukreja R, Desilets D, Karimian K, Tam TF. 1,2,4-thiadiazole: a novel Cathepsin B inhibitor. Bioorg Med Chem. 2003 Dec 1;11(24):5529–37. |
Calpain inhibitor II | N-Acetyl-Leu-Leu-Methional | Reversible inhibitor | synthesized | Sasaki T, Kishi M, Saito M, Tanaka T, Higuchi N, Kominami E, Katunuma N, Murachi T. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and Cathepsins. J Enzyme Inhib. 1990;3(3):195–201. |
Peptidyl cyclopropenone 9 | Peptidyl cyclopropenone 9 (the S isomer) | Reversible inhibitor | synthesized | Cohen M, Bretler U, Albeck A. Peptidyl cyclopropenones: reversible inhibitors, irreversible inhibitors, or substrates of cysteine proteases? Protein Sci. 2013 Jun;22(6):788–99. |
shRNA-CTSB#2 | oligonucleotide | RNA interference inhibitor | synthesized | Bao W, Fan Q, Luo X, Cheng WW, Wang YD, Li ZN, Chen XL, Wu D. Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer. Oncol Rep. 2013 Aug;30(2):723–30. |
DARPin 8h6 | ankyrin repeat protein | antibody-drug conjugate like inhibitor | synthesized | Kramer L, Renko M, Završnik J, Turk D, Seeger MA, Vasiljeva O, Grütter MG, Turk V, Turk B. Non-invasive in vivo imaging of tumour-associated Cathepsin B by a highly selective inhibitory DARPin. Theranostics. 2017 Jul 8;7(11):2806–21. |
Concanamycin A | designated folimycin | Indirect inhibitor (by specific inhibiton of V-ATPase) | synthesized | Uhlman A, Folkers K, Liston J, Pancholi H, Hinton A. Effects of Vacuolar H(+)-ATPase Inhibition on Activation of Cathepsin B and Cathepsin L Secreted from MDA-MB231 Breast Cancer Cells. Cancer Microenviron. 2017 Dec;10(1–3):49–56. |